Samuel Bjork

Samuel Bjork

Director/Board Member at
EpiBiologics, Inc.
Consumer Services
Finance
Health Technology

Profile

Samuel Bjork is currently a Director at PetMedix Ltd., Bonum Therapeutics, Inc., and EpiBiologics, Inc. He is also a Partner at Digitalis Ventures LLC.
Previously, he worked as a Strategic Advisor at Columbia Technology Ventures.
He received his undergraduate degree from Harvard University and his graduate degrees from the University of Oxford and the University of Cambridge.

Samuel Bjork active positions

CompaniesPositionStart
Private Equity Investor 2016-12-31
Director/Board Member -
Director/Board Member 2023-07-19
Director/Board Member -

Former positions of Samuel Bjork

CompaniesPositionEnd
Consultant / Advisor 2017-01-31
See the detail of Samuel Bjork's experience

Training of Samuel Bjork

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

96

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Consumer Services

Consumer Services

Consumer Services

Finance

Finance

Health Technology

Commercial Services

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!